Phibro Animal Health Corporation (NASDAQ:PAHC)‘s stock had its “buy” rating reiterated by research analysts at Piper Jaffray Companies in a research note issued on Friday. They currently have a $35.00 target price on the stock. Piper Jaffray Companies’ price target indicates a potential downside of 8.62% from the stock’s previous close.

Several other equities analysts also recently weighed in on PAHC. Credit Suisse Group downgraded shares of Phibro Animal Health Corporation from an “outperform” rating to a “neutral” rating and increased their price target for the stock from $29.00 to $36.00 in a report on Friday, June 2nd. BidaskClub downgraded shares of Phibro Animal Health Corporation from a “strong-buy” rating to a “buy” rating in a report on Wednesday, June 14th. Finally, Zacks Investment Research upgraded shares of Phibro Animal Health Corporation from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Thursday, May 11th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating, four have assigned a buy rating and one has given a strong buy rating to the stock. Phibro Animal Health Corporation presently has a consensus rating of “Hold” and a consensus price target of $30.50.

Shares of Phibro Animal Health Corporation (NASDAQ PAHC) traded up 1.46% during mid-day trading on Friday, reaching $38.30. 185,480 shares of the company traded hands. The firm has a 50-day moving average price of $36.60 and a 200 day moving average price of $31.09. Phibro Animal Health Corporation has a 52 week low of $19.02 and a 52 week high of $38.85. The firm has a market capitalization of $1.52 billion, a price-to-earnings ratio of 23.79 and a beta of 1.35.

Phibro Animal Health Corporation (NASDAQ:PAHC) last announced its quarterly earnings data on Monday, May 8th. The company reported $0.37 EPS for the quarter, meeting the Thomson Reuters’ consensus estimate of $0.37. Phibro Animal Health Corporation had a net margin of 8.49% and a return on equity of 54.68%. The firm had revenue of $190 million during the quarter, compared to analyst estimates of $185.90 million. During the same period last year, the firm posted $0.38 EPS. Phibro Animal Health Corporation’s revenue was up 3.5% on a year-over-year basis. On average, analysts anticipate that Phibro Animal Health Corporation will post $1.45 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Piper Jaffray Companies Reaffirms “Buy” Rating for Phibro Animal Health Corporation (NASDAQ:PAHC)” was originally posted by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another site, it was copied illegally and republished in violation of United States & international copyright laws. The legal version of this piece of content can be read at https://www.dailypolitical.com/2017/07/21/piper-jaffray-companies-reaffirms-buy-rating-for-phibro-animal-health-corporation-nasdaqpahc.html.

In other news, Director Gerald K. Carlson sold 63,338 shares of the firm’s stock in a transaction that occurred on Thursday, May 11th. The shares were sold at an average price of $33.31, for a total transaction of $2,109,788.78. Following the sale, the director now owns 50 shares of the company’s stock, valued at approximately $1,665.50. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, COO Larry Lee Miller sold 14,780 shares of the firm’s stock in a transaction that occurred on Monday, May 1st. The stock was sold at an average price of $30.13, for a total transaction of $445,321.40. Following the sale, the chief operating officer now directly owns 4,397 shares in the company, valued at approximately $132,481.61. The disclosure for this sale can be found here. In the last quarter, insiders sold 515,296 shares of company stock worth $17,788,794. 48.09% of the stock is owned by corporate insiders.

Several large investors have recently modified their holdings of the company. State of Alaska Department of Revenue boosted its stake in shares of Phibro Animal Health Corporation by 80.9% in the second quarter. State of Alaska Department of Revenue now owns 3,690 shares of the company’s stock worth $136,000 after buying an additional 1,650 shares during the last quarter. Mason Street Advisors LLC boosted its stake in shares of Phibro Animal Health Corporation by 7.1% in the first quarter. Mason Street Advisors LLC now owns 4,333 shares of the company’s stock worth $122,000 after buying an additional 286 shares during the last quarter. Victory Capital Management Inc. boosted its stake in shares of Phibro Animal Health Corporation by 79.2% in the first quarter. Victory Capital Management Inc. now owns 4,573 shares of the company’s stock worth $129,000 after buying an additional 2,021 shares during the last quarter. New York State Teachers Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 1.4% in the fourth quarter. New York State Teachers Retirement System now owns 7,343 shares of the company’s stock worth $215,000 after buying an additional 100 shares during the last quarter. Finally, Louisiana State Employees Retirement System boosted its stake in shares of Phibro Animal Health Corporation by 1.4% in the first quarter. Louisiana State Employees Retirement System now owns 7,500 shares of the company’s stock worth $211,000 after buying an additional 100 shares during the last quarter. 47.62% of the stock is currently owned by institutional investors and hedge funds.

Phibro Animal Health Corporation Company Profile

Phibro Animal Health Corporation (Phibro) is a global diversified animal health and mineral nutrition company. The Company operates in three segments, which include Animal Health, Mineral Nutrition and Performance Products. The Company offers various products, which include Animal health products, such as antibacterials, anticoccidials, vaccines, nutritional specialty products and mineral nutrition products.

Analyst Recommendations for Phibro Animal Health Corporation (NASDAQ:PAHC)

Receive News & Ratings for Phibro Animal Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corporation and related companies with MarketBeat.com's FREE daily email newsletter.